Bryant v. Wake Forest Univ. Baptist Med. Ctr.

CourtCourt of Appeals of North Carolina
DecidedFebruary 15, 2022
Docket21-138
StatusPublished

This text of Bryant v. Wake Forest Univ. Baptist Med. Ctr. (Bryant v. Wake Forest Univ. Baptist Med. Ctr.) is published on Counsel Stack Legal Research, covering Court of Appeals of North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bryant v. Wake Forest Univ. Baptist Med. Ctr., (N.C. Ct. App. 2022).

Opinion

IN THE COURT OF APPEALS OF NORTH CAROLINA

2022-NCCOA-89

No. COA21-138

Filed 15 February 2022

Forsyth County, No. 18 CVS 5491

KIMBERLY D. BRYANT, Plaintiff,

v.

WAKE FOREST UNIVERSITY BAPTIST MEDICAL CENTER, NORTH CAROLINA BAPTIST HOSPITAL, WAKE FOREST UNIVERSITY HEALTH SCIENCES, & MEHMET TAMER YALCINKAYA, M.D., Defendants.

Appeal by Plaintiff from order granting Defendants’ motion for summary

judgment entered 23 October 2020 by Judge Eric C. Morgan in Forsyth County

Superior Court. Heard in the Court of Appeals 16 November 2021.

Kennedy, Kennedy, Kennedy, & Kennedy, LLP, by Harvey L. Kennedy and Harold L. Kennedy, III, for Plaintiff-Appellant.

Coffey Law PLLC, by Tamura D. Coffey, Elizabeth G. Horton, and Peyton M. Pawlik, for Defendant-Appellee Mehmet Tamer Yalcinkaya, M.D.

Shumaker, Loop & Kendrick, LLP, by Scott M. Stevenson, John D. Kocher, and Christopher T. Hood, for Defendant-Appellees Wake Forest University Baptist Medical Center, North Carolina Baptist Hospital, and Wake Forest University Health Sciences.

JACKSON, Judge.

¶1 Kimberly D. Bryant (“Plaintiff”) appeals from an order granting Mehmet

Tamer Yalcinkaya, M.D., Wake Forest University Baptist Medical Center, North BRYANT V. WAKE FOREST UNIV. BAPTIST MED. CTR.

Opinion of the Court

Carolina Baptist Hospital, and Wake Forest University Health Sciences’ (collectively

“Defendants”) motion for summary judgment. Plaintiff argues that the trial court

erred because a genuine issue of material fact existed for her fraudulent concealment,

res ipsa loquitor, medical malpractice, and punitive damages claims. We affirm the

trial court’s grant of summary judgment for each of Plaintiff’s claims.

I. Background

¶2 In 2007, Plaintiff was referred to Mehmet Tamer Yalcinkaya, M.D.

(“Defendant Yalcinkaya”), a reproductive endocrinologist, due to pelvic pain caused

by a large uterine myoma, also known as a uterine fibroid. At that time, Defendant

Yalcinkaya was an attending physician, associate professor, and the Reproductive

Endocrinology and Infertility (“REI”) Section Head at Wake Forest University

Baptist Medical Center in Winston-Salem. Defendant Yalcinkaya was a physician

licensed in North Carolina and board-certified in both Obstetrics and Gynecology

(“OB-GYN”) and REI.

¶3 After examining Plaintiff, Defendant Yalcinkaya confirmed her uterine myoma

diagnosis and recommended an exploratory laparotomy (abdominal surgery) and

myomectomy (surgical removal of uterine fibroids). After Plaintiff consented to the

surgical course of treatment, Defendant Yalcinkaya performed the surgery on 5

October 2007. During the procedure, Defendant Yalcinkaya determined that Plaintiff BRYANT V. WAKE FOREST UNIV. BAPTIST MED. CTR.

had Stage IV endometriosis, an advanced form of a disorder that results in abnormal

endometrial tissue growth outside the uterus, which had affected Plaintiff’s uterus,

fallopian tubes, ovaries, and uterine cul-de-sac—meaning that Plaintiff’s pelvis was

largely covered with adhesions and scar tissue. Defendant Yalcinkaya removed

Plaintiff’s large uterine fibroid and many of the endometrial adhesions. After the

surgery, Defendant Yalcinkaya documented and diagrammed the extent of Plaintiff’s

endometriosis, and noted in her chart that her prognosis regarding fertility was

guarded even with removal of the fibroid and the assistance of in vitro fertilization

(“IVF”). Plaintiff alleged that Defendant Yalcinkaya told her and her husband after

the surgery “to rest for three months, and after that there was no reason she couldn’t

get pregnant and have a child.”

¶4 Near the end of the surgery, Defendant Yalcinkaya implanted a prelude

peritoneal membrane, also known as a Gore-Tex adhesion barrier, to prevent

adhesions from forming at the surgical incision site where the fibroid was removed.

Defendant Yalcinkaya used non-absorbable sutures when implanting the Gore-Tex

barrier, in order to keep it in place permanently. The use of the Gore-Tex barrier was

documented in Defendant Yalcinkaya’s operative note for the procedure, as well as in

the perioperative record of the procedure. The Gore-Tex barrier was specifically

listed under the “Implants” section of the operative note, with the serial number, lot

number, and model number of the barrier listed along with other information. This BRYANT V. WAKE FOREST UNIV. BAPTIST MED. CTR.

type of surgical membrane was routinely used in 2007 to prevent pelvic adhesion

formation. Defendant Yalcinkaya testified that he used the implant to prevent

adhesion formation at the incision site and increase Plaintiff’s fertility and chance of

carrying a child to term.

¶5 After the procedure, Plaintiff saw Defendant Yalcinkaya for post-operative

treatment. Defendant Yalcinkaya recommended and noted in her chart that Plaintiff

undergo drug therapy to inhibit uterine fibroid growth as well as a second procedure

to evaluate her endometriosis and remove additional fibroids and endometrial

adhesions. Defendant Yalcinkaya says he told Plaintiff this during an office visit on

9 October 2007 and another visit on 18 December 2007, but Plaintiff asserts this was

never communicated to her. Plaintiff did not complete drug therapy or undergo a

second surgery, and her last office visit with Defendant Yalcinkaya was 5 March

2008. At this last appointment, Plaintiff indicated that she did not know when she

might want to become pregnant and discontinued her treatment with Defendant

Yalcinkaya.

¶6 In December 2016, Plaintiff returned to the Wake Forest gynecology clinic for

treatment of a large pelvic mass. On 21 February 2017, Plaintiff presented for

surgery to E. Johnston-MacAnanny, M.D. (“Dr. Johnston”), who performed an

exploratory laparotomy with adhesiolysis, evaluating and draining Plaintiff’s pelvic

mass. During this procedure, Dr. Johnston found and removed the Gore-Tex implant BRYANT V. WAKE FOREST UNIV. BAPTIST MED. CTR.

that had been placed by Defendant Yalcinkaya almost ten years prior. At the time,

Dr. Johnston did not know what the object was, and initially thought it could be a

sheet of plastic. After lab analysis, it was later discovered to be the Gore-Tex implant.

¶7 On 21 September 2017, Plaintiff filed suit against Wake Forest University

Baptist Medical Center, North Carolina Baptist Hospital, Wake Forest University

Health Sciences, and Defendant Yalcinkaya (collectively “Defendants”) alleging that

the Gore-Tex barrier implanted by Defendant Yalcinkaya caused her infertility. On

16 February 2018, Plaintiff voluntarily dismissed the suit without prejudice, and filed

a new complaint on 25 October 2018, naming the same defendants.

¶8 On 12 March 2020, Plaintiff’s standard of care expert, Steven D. McCarus,

M.D. (“Dr. McCarus”), was deposed. During his deposition, Dr. McCarus testified in

relevant part that

 In 2007, there were three types of FDA-approved implants to prevent post-

surgical adhesion formation, one of which was the Gore-Tex barrier used in

this case.

 Adhesion barriers have a therapeutic purpose, and in 2006 and 2007, Gore-Tex

adhesion barriers had therapeutic purposes.

 At the time of Plaintiff’s procedure, there was no medical literature suggesting

that any of the adhesion barriers were superior; it was simply the surgeon’s

preference as to which FDA-approved implant to use.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Black v. Littlejohn
325 S.E.2d 469 (Supreme Court of North Carolina, 1985)
Dobson v. Harris
530 S.E.2d 829 (Supreme Court of North Carolina, 2000)
Locklear v. Lanuti
626 S.E.2d 711 (Court of Appeals of North Carolina, 2006)
Carolina Power & Light Co. v. City of Asheville
597 S.E.2d 717 (Supreme Court of North Carolina, 2004)
Rowell v. Bowling
678 S.E.2d 748 (Court of Appeals of North Carolina, 2009)
Watts v. Cumberland County Hospital System, Inc.
343 S.E.2d 879 (Supreme Court of North Carolina, 1986)
Hensell v. Winslow
416 S.E.2d 426 (Court of Appeals of North Carolina, 1992)
Iadanza v. Harper
611 S.E.2d 217 (Court of Appeals of North Carolina, 2005)
State v. Coffey
444 S.E.2d 431 (Supreme Court of North Carolina, 1994)
Grassy Creek Neighborhood Alliance, Inc. v. City of Winston-Salem
542 S.E.2d 296 (Court of Appeals of North Carolina, 2001)
Piraino Bros. v. Atlantic Financial Group, Inc.
712 S.E.2d 328 (Court of Appeals of North Carolina, 2011)
Dallaire v. Bank of America, N.A.
760 S.E.2d 263 (Supreme Court of North Carolina, 2014)
Ussery v. Branch Banking & Trust Co.
777 S.E.2d 272 (Supreme Court of North Carolina, 2015)
Mitchell v. . Saunders
13 S.E.2d 242 (Supreme Court of North Carolina, 1941)
Bluitt v. Wake Forest Univ. Baptist Med. Ctr.
814 S.E.2d 477 (Court of Appeals of North Carolina, 2018)
Head v. Gould Killian Cpa Grp., P.A.
812 S.E.2d 831 (Supreme Court of North Carolina, 2018)
Mitchell v. Saunders
219 N.C. 178 (Supreme Court of North Carolina, 1941)
Funderburk v. JPMorgan Chase Bank, N.A.
775 S.E.2d 1 (Court of Appeals of North Carolina, 2015)
Smith v. Axelbank
730 S.E.2d 840 (Court of Appeals of North Carolina, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Bryant v. Wake Forest Univ. Baptist Med. Ctr., Counsel Stack Legal Research, https://law.counselstack.com/opinion/bryant-v-wake-forest-univ-baptist-med-ctr-ncctapp-2022.